University of California, Los Angeles: Heart Diseases trials
The registry lists 13 Heart Diseases studies with University of California, Los Angeles as lead sponsor. 0 are open to participants now and 5 have results posted.
Phase 2 3Phase 3 2Phase 4 1No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Specialized Pacing for Patients With Congenital Heart DiseaseTerminatedNCT03361189Phase 2/3Results posted
- Anesthetic Techniques in EP PatientsTerminatedNCT02664922Phase 4Results posted
- A Clinical Trial for People HIV+ Age > 50 at Risk for Heart DiseaseCompletedNCT01578772Phase 2Results posted
- Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart DiseaseTerminatedNCT01319045Not applicableResults posted
- Endothelin Blockade in Patients With Single Ventricle PhysiologyCompletedNCT00989911Not applicableResults posted
- Acute Normovolemic Hemodilution in Complex Cardiac SurgeryCompletedNCT05049590Phase 3
- Smarter Care Virginia, Examining Low-Value Care in VirginiaCompletedNCT04053335
- Cognitive Intervention to Improve Working MemoryCompletedNCT03687008Not applicable
- Heart and Lung Function Monitoring SystemCompletedNCT02168049Not applicable
- Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary HypertensionWithdrawnNCT01980979Not applicable
- Promotora-based Latino Family CVD Risk ReductionCompletedNCT01714271Phase 2
- Comparison Endotracheal Cardiac Output Monitor (ECOM) to a Standard Device in Measuring Heart Blood VolumeCompletedNCT00883857
- Pharmacogenetics of Hypertriglyceridemia in HispanicsCompletedNCT00086437